ClinicalTrials.gg

BiologicalDrug

Escherichia coli lipopolysaccharide clinical trials

studies test it
13
open now
1
in phase 3
0
first study started
2002

Keep track of what changes. Save the escherichia coli lipopolysaccharide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

13 studies that test it; most in 2018 (3)

Studies that test escherichia coli lipopolysaccharide, by start year
YearStudies
20021
20031
20041
20061
20101
20131
20141
20183
20191
20211
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
6
Phase 2
1
No phase
5

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 2 · Other 11

University of North Carolina, Chapel Hill (2) · Janssen Research & Development, LLC (1) · Yale University (1) · Radboud University Medical Center (1) · University of Aberdeen (1) · University of Aarhus (1) · Medical University of Vienna (1) · Laureate Institute for Brain Research, Inc. (1)

Often tested with

Tested in the same studies.

MVA-BN smallpox vaccine (1) · Shingrix (1) · Candida albicans Antigen Injection (1) · GSK3358699 (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)

Studies

Open first, then newest update. How each study uses escherichia coli lipopolysaccharide is read from its arms, and is right about nine times in ten.

Testing it · 13

Given in every arm · 2 — escherichia coli lipopolysaccharide is usual care beside what is tested